Free tool
Stocks listed on XETRA
We cover 32 companies listed on XETRA. The median market value in the group is $1.08B. Across the group, the median move over the past trading day is 0.00%. 55% of the 29 with a 200-day average trade above it. Price change over the past year runs from −38.9% to +70.6% across the middle 80 percent of the group, with a median of −4.0%.
Other lists in this group
Table
32 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.84B | Small cap | +53.42% |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% |
| 2HQ0.DE | Tilray Brands, Inc. | $657.67M | Small cap | −67.56% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| FYB.DE | Formycon AG | $410.04M | Small cap | −25.04% |
| M12.DE | M1 Kliniken AG | $401.97M | Small cap | +37.84% |
| ILM1.DE | Medios AG | $324.14M | Small cap | −26.32% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $316.56M | Small cap | +47.70% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| VME.DE | Viromed Medical AG | $164.76M | Small cap | +85.71% |
| HPHA.DE | Heidelberg Pharma AG | $135.27M | Small cap | −31.15% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.